Lady Hardinge Medical College   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: New Delhi India (1916)

Organization Overview

First Clinical Trial
2005
NCT01412567
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Lady Hardinge Medical College | Lady Hardinge Medical College and Associated Hospitals | Lady Hardinge Medical College & Kalawati Saran Children's Hospital | Lady Hardinge Medical College, New Delhi | Lady Hardinge Medical College, New Delhi, India | LADY HARDINGE MEDICAL COLLEGE,NEW DELHI,INDIA | Suvasini Sharma

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Birth Weight (Phase 3)

Epilepsy (Phase 3)

Premature Birth (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Rickets (Phase 4)

Spasm (Phase 3)

Spasms, Infantile (Phase 3)

Syndrome (Phase 3)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 21